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Abstract 
 
Diabetic retinopathy is one of the most frequent complications of diabetes and is 
a leading cause of vision loss in adulthood. To better understand the molecular 
pathophysiology of diabetic retinopathy, we performed comprehensive gene 
expression analysis of the mouse retina under diabetic conditions with an in-house 
cDNA microarray system that was designed to be suitable for the small amount of 
RNA available from a single mouse retina. Diabetes was induced in male C57BL/6 
mice by an intraperitoneal injection of streptozotocin, and the changes in retinal 
mRNA levels were examined in three pairs of diabetic and age-matched control mice 
at 1 and 3 months after the injection of streptozotocin. Northern blot analysis with 
amplified total cRNA confirmed the increase in mRNA levels of several selected 
genes. Most of the significantly up-regulated genes could be classified into two 
functional categories: oxidative phosphorylation and protein turnover. All 
mitochondrial DNA-encoded and most of the nuclear DNA-encoded genes for 
oxidative phosphorylation were up-regulated in the diabetic retina. This was in sharp 
contrast with a previous report of a down-regulation of these genes in skeletal 
muscles of streptozotocin-induced diabetic mice and type 2 diabetic humans. Genes 
for protein synthesis and ubiquitin were also up-regulated in the diabetic retina, 
suggesting the increase in turnover rates for at least a part of the protein population. 
Taken together, the diabetic retina appears to be in a state activated for intermediary 
metabolism, presumably because of an increase in insulin-independent glucose 
influx. These results provide insights into possible preventive and therapeutic 
intervention of diabetic retinopathy. 
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1. Introduction 
 
Diabetic retinopathy is one of the most frequent complications of diabetes and is 
a leading cause of vision loss in adulthood. Historically, ophthalmoscopically 
observable vascular changes of the diabetic retina have been emphasized as the 
cause of the retinopathy, i.e., increased vascular permeability due to breakdown of 
blood-retinal barrier (BRB) is manifested as macular edema followed by 
microaneurysms and hemorrhages, ultimately leading to vascular proliferation. 
Recently, several aberrations of retino-neural functions have been reported to 
precede the obvious vascular changes (Barber, 2003; Reiter and Gardner, 2003); 
e.g., abnormalities in the electroretinogram were detected in the early diabetes, and 
they were accompanied by the deficits in night vision and contrast sensitivity 
especially in color vision. It appears that all of the major retinal cell types such as 
neurons, macroglias and microglias, as well as vascular cells, are involved in the 
pathogenesis of diabetic retinopathy (Gardner et al., 2002). 
Comprehensive gene expression analysis with DNA microarrays is a powerful 
tool to investigate the etiology and pathophysiology of diseases including diabetic 
retinopathy in mouse models. Attempts have been made to prepare and/or analyze 
DNA microarrays for the rodent retina (Cho et al., 2002; Farjo et al., 2002; Joussen 
et al., 2001; Sato et al., 2003). In general, the relatively small amount of RNA that 
can be obtained from a mouse retina hampers the construction and analysis of 
cDNA microarrays. Recently, we developed a system, named the widely-applicable 
cDNA/cRNA system, that is suitable both for the construction of a cDNA library and 
for the measurement of the mRNA levels with several options of hybridization 
analysis with cDNA and cRNA amplified from a small amount of mRNA (Ohtsuka et 
al., 2004). We have applied this system to the preparation of the cDNA microarray 
followed by its analysis and confirmation of the obtained results from a single mouse 
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retina. 
Historically, diabetic rats produced by treating them with streptozotocin (STZ) 
have been used extensively for analysis of retinopathy including gene expression 
profiling with microarrays. A number of genes for inflammatory process were 
reported to be up- or down-regulated especially during the first week of STZ-induced 
diabetes in rat retinas (Joussen et al., 2001). Müller cells of rat retinas after 6 
months of diabetes also exhibited activation of inflammation-related genes including 
those for acute phase response proteins (Gerhardinger et al., 2005). A recent 
microarray study (Knoll et al., 2005) found that the gene response in STZ-induced 
diabetes is largely different among rat tissues such as the renal cortex, cardiac left 
ventricle, skeletal muscle, and retina.  
Compared to rats, studies on diabetic retinopathy of STZ-treated mice are 
limited, but the features of the retinopathy have been described including the 
vascular changes (Hammes et al., 2002), increased levels of caspase activation, a 
marker of apoptosis (Mohr et al., 2002), and neuronal cell loss (Martin et al., 2004). 
Because of its advanced genetics, the mouse provides a growing number of useful 
models of human diseases, as was exemplified by the Ins2Akita mouse with a 
mutation in the insulin 2 gene and exhibiting diabetic retinopathy with vascular, 
neural, and glial abnormalities (Barber et al., 2005). 
The purpose of this study was to determine the gene expression profiles in 
retinas of diabetic mice 1 and 3 months after STZ injection. We found that genes 
involved in oxidative phosphorylation and protein turnover were activated. This was 
strikingly different from previous observations for gene expression profiles in the 
skeletal muscle of STZ-induced diabetic mice (Yechoor et al., 2002; Yechoor et al., 
2004) and type 2 diabetic humans (Mootha et al., 2003; Reiter and Gardner, 2003), 
revealing characteristic features of gene regulation in the diabetic retina. 
 
5 
2. Materials and methods 
 
2.1. Experimental animals  
 
All experimental procedures complied with the ARVO Statement for the Use of 
Animals in Ophthalmic and Vision Research. Animals were group-housed with full 
access to food and water at a room temperature of 23 ± 1°C in a 12-h light/12-h 
dark cycle. To induce diabetes, 8-week-old male C57BL/6 mice were injected 
intraperitoneally with 200 mg/kg STZ (Sigma, St. Louis, MO) in 0.4 ml of 50 mM 
citrate (pH 4.5)/154 mM NaCl. Insulin was not administered to the mice throughout 
the experiment. Control mice were injected with the citrate buffer only. The glucose 
levels in blood samples taken from the tail vein were measured by the glucose 
dehydrogenase/potassium ferricyanide method with the Advantage II glucose meter 
(Roche Diagnostics, Tokyo, Japan). The statistical significance of differences of 
blood glucose levels and body weights between groups was evaluated using 
Student's t-test. P < 0.05 was considered significant. Data are shown as mean ± 
S.E. 
Mice were killed by ether anesthesia, and the eyes were enucleated by cutting 
the optic nerve just behind the eyeball. Then the anterior segment of the eye was cut 
away, and the retina was carefully isolated from the retinal pigment epithelium layer 
with forceps. The isolated retina appeared clear, and no pigmentation was seen 
under the microscope, indicating that the retina was free from retinal pigment 
epithelial cells. Total RNA was prepared from the mouse retina with TRIzol reagent 
(Invitrogen Corp., Carlsbad, CA), and the yield of RNA was about 4 μg from a single 
retina. 
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2.2. Preparation of mouse retina cDNA library 
 
The cDNA library was constructed from the mouse retina as schematically 
represented in Steps 1-8 of Fig.1. Detailed procedures for Steps 1, 2, and 4-8 were 
described previously (Ohtsuka et al., 2004). Briefly, poly(A)+ RNA derived from 1 μg 
of total RNA was adsorbed onto 50 μg of oligo(dT)-paramagnetic beads, Dynabeads 
Oligo(dT)25 (Dynal, Oslo, Norway) (Step 1), and was subjected to antisense-strand 
cDNA synthesis with reverse transcriptase, followed by sense-strand cDNA 
synthesis-coupled replacement reaction with Escherichia coli DNA polymerase I, 
DNA ligase, and RNase H (Step 2). The resulting bead-fixed double-stranded cDNA 
was divided into three aliquots, which were each digested with one of three 
restriction enzymes BanI, EcoO109I and HincII (Step 3). Each of these enzymes 
cuts random DNA sequences once on an average of every 1,024 bp length, 
preventing the loss of long cDNA species in the following PCR steps. The bead-fixed 
3'-trimmed cDNAs were mixed, blunt-ended, and ligated with 1 μg of the linker 
containing the T7 promoter sequence (Step 4). The sense-strand cDNA was 
liberated by heat-denaturation (Step 5), and was again converted to the 
double-stranded form with priming from the oligo(dT) primer containing the SP6 
promoter sequence (Step 6). The double-stranded cDNA was amplified with PCR 
using known sequences at both ends as primers (Step 7). Restriction ends for AvaI 
5'-CCGG-3' and AccI 5'-CG-3' were constructed on 5' and 3' terminals, respectively, 
of the amplified cDNA with exonuclease activity of T4 DNA polymerase in the 
presence of dATP and dTTP but in the absence of dCTP and dGTP. This allowed a 
unidirectional ligation with AvaI/AccI-cut pUC19 (Step 8) after gel-purification of 
cDNA fragments longer than 800 bp with glass powder Glassmilk (Qbiogene, 
Montreal, Canada). The ligation products were subjected to transformation of E. coli 
strain DH10B (Invitrogen). Nucleotide-sequencing from the 5' end of 2,880 cDNA 
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clones allowed them to be classified into about 1,900 distinct genes. 
 
2.3. Preparation of cDNA microarray 
 
A microarray chip harboring the 2,880 retinal cDNAs was prepared (Step 9), 
essentially as described (Yoshikawa et al., 2000). Briefly, PCR-amplified cDNAs 
were mixed with nitrocellulose, and spotted onto carbodiimide-coated glass slides 
(Nisshinbo Industries, Inc., Chiba, Japan) with a robotics SPBIO-2000 (Hitachi 
Software Engineering Co., Yokohama, Japan). 
 
2.4. Microarray analysis 
 
Target mixtures were prepared, and hybridization was carried out as follows 
(Fig. 1, Steps 1, 2, and A to D). The bead-fixed double-stranded cDNA derived from 
2 μg of total RNA was synthesized as described (Steps 1 and 2), and ligated with 1 
μg of the T7 promoter-linker (Step A). In vitro transcription of sense-strand cRNA 
(Step B) was carried out with a kit for T7 RNA polymerase AmpliScribe T7 
(Epicentre, Madison, WI) in 20 μl of the reaction mixture at 37°C for 2 hr. The 
cDNA-beads were separated magnetically, and the synthesized cRNA in the 
supernatant was collected by ethanol precipitation. Typically, 10 μg of sense-strand 
cRNA were obtained, and 0.6 μg of the cRNA was used as a template for reverse 
transcription-coupled incorporation of 5-(3-aminoallyl)-dUTP (Ambion Inc., Austin, 
TX) into antisense-strand cDNA, which was in turn postlabeled with Cy3 or Cy5 with 
the Mono-Reactive Dye Pack (Amersham Biosciences, Tokyo, Japan) using 
standard procedures according to manufacturer’s’ protocols. The Cy3- and Cy5- 
labeled cDNAs (each 9 μl) were mixed and made up to 40 μl of the solution 
containing 1.25 μg/μl of yeast tRNA, 1.25 μg/μl of poly(A), 25 ng/μl of the upper 
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strand of the T7 promoter-linker, 25 ng/μl of the SP6 promoter/oligo(dT)-primer, 3.4 x 
SSC [1 x SSC: 0.15 M NaCl/15 mM sodium citrate], and 0.3% SDS. The mixture 
was hybridized with the microarray at 65°C overnight under humidified conditions. 
The array was washed twice for 10 min with 2 x SSC/0.1% SDS at room 
temperature, and twice for 10 min with 0.2 x SSC/0.1% SDS at 40°C. After 
centrifugation at 2,000 rpm for 1 min and air-drying, the array was scanned with a 
fluorescence laser-scanning device (ScanArray4000; GSI Lumonics, Bedford, MA). 
 
2.5. Data analysis 
 
Microarray images were analyzed with the Quant Array software (GSI 
Lumonics). The median for each of Cy3 and Cy5 fluorescence intensities of 656 
blank spots in the array was used as the background value. Spots with Cy3 or Cy5 
intensities greater than the median of the background-subtracted intensities at least 
once in the whole set of array analyses were subjected to significance analysis of 
microarrays (SAM) (Tusher et al., 2001) for the detection of significant changes in 
mRNA levels. The significance for each gene of functionally-classified categories 
was evaluated by the test of population means. 
 
2.6. Northern analysis 
 
Sense-strand cRNAs (0.25 μg per lane) transcribed from the bead-fixed cDNAs 
(Fig. 1, Step B) were electrophoresed in denaturing formaldehyde-agarose (1%) gels. 
RNAs were made visible by ethidium bromide staining and blotted onto nylon 
membranes. The cDNA-harboring plasmids were linearized by digestion with a 
restriction enzyme XbaI or XhoI whose site resides in the T7 promoter-linker (Step 
10). They were then subjected to synthesis of DIG-cRNA probes by in vitro 
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transcription with SP6 RNA polymerase (Step 11), using DIG RNA Labeling Kit 
(Roche Diagnostics). Northern hybridization of the blotted membrane (Step E) and 
following chemiluminescent detection on X-ray films were done as recommended by 
Roche Diagnostics. Densitometric quantification was performed by Personal 
Scanning Image PDSI (Molecular Dynamics, Sunnyvale, CA). 
 
 
3. Results 
 
3.1. Construction of cDNA microarray from mouse retina 
 
Our system enabled both the preparation (Fig. 1, Steps 1-9) and analyses 
(Steps A-D) of the in-house cDNA microarray with a small amount of RNA derived 
from a single mouse retina. In addition, the results obtained from the array analysis 
could be confirmed by Northern analysis (Steps 10, 11, and E) with the same cDNA 
clones and the amplified cRNAs used in the array experiments. A cDNA library was 
constructed from the mouse retina, and the nucleotide sequences of 2,880 clones at 
the 5' end of cDNA inserts were determined, leading to the classification of the 
clones into about 1,900 gene clusters. Categories of the 2,880 clones are shown in 
Fig. 2. A previous study using the serial analysis of gene expression (SAGE) method 
identified a number of genes specifically expressed in the retina (Blackshaw et al., 
2001), among which most frequently expressed were genes for rhodopsin, rod 
arrestin (S-antigen), phosducin, transducin G proteins, cGMP-phosphodiesterase 
subunits, and rod outer segment membrane protein 1. The cDNA clones for these 
genes in the present study accounted for 4.4% of the total sequenced clones (Fig.2, 
Category 2). The percentage was approximately the same as that obtained in 
previous studies on expression profiles of the retinas of mice (Blackshaw et al., 
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2001) and humans (Sharon et al., 2002; Shimizu-Matsumoto et al., 1997). This was 
concordant with the notion that our cDNA library and microarray are representative 
of the mRNA population of the mouse retina. Previous studies also reported that 
genes involved in energy production and protein synthesis were highly expressed in 
the retina (Sharon et al., 2002; Shimizu-Matsumoto et al., 1997), reflecting the high 
energy consumption and protein turnover of the retina, respectively. Consistent with 
this view, cDNA clones for mitochondrial DNA-encoded proteins and for protein 
synthesis made up a substantial portion of the total clones, 13.2% and 2.5%, 
respectively (Categories 1 and 3). A microarray that harbors these 2,880 retinal 
cDNAs and other 192 cDNAs was then prepared. 
 
3.2. General features of cDNA microarray analysis for diabetic mouse retina 
 
Each of 3 pairs of a diabetic and age-matched control mouse at 1 and 3 months 
after STZ injection was subjected to cDNA microarray analysis for a total of 6 
hybridization experiments. The time points of 1 and 3 months were selected based 
on previous studies describing the onsets of diabetes-induced morphological and 
functional abnormalities such as a significant increase in the frequency of apoptosis 
in rat retinas at 1 and 3 months after STZ injection (Barber, 1998), and in mouse 
retinas 10 weeks after the injection (Martin et al., 2004).  
Blood glucose levels of STZ-treated mice were increased compared to 
saline-injected control mice significantly at 1 month (472.3 ± 103.0 mg/dl vs 151.7 
± 10.0 mg/dl, P < 0.05), and apparently at 3 months (> 600, > 600, and 569 mg/dl 
for each of STZ-treated mice vs 153.3 ± 6.4 mg/dl for control mice). Body weights 
of STZ-treated mice were reduced compared to control mice significantly both at 1 
month (19.8 ± 3.9 g vs 29.5 ± 1.0 g, P < 0.05), and at 3 months (18.2 ± 1.9 g 
vs 36.1 ± 3.3 g, P < 0.01). 
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To prepare the target mixtures (Fig. 1, Steps 1, 2, and A to C), sense-strand 
cRNA was subjected to Cy3- or Cy5-labeling of antisense-strand cDNA. For two 
pairs of mice, these target cDNAs derived from diabetic mice were Cy5-labeled, and 
those from control mice Cy3-labeled. For another pair of mice, labeling with Cy5 and 
Cy3 was interconverted to compensate for possible biases such as 
intensity-dependent fluorescence variations of the two dyes (Quackenbush, 2002). 
The Cy3- and Cy5-labeled target cDNAs were mixed and hybridized with the 
microarrays.  
There were 2,446 spots with Cy3 or Cy5 fluorescence intensities higher than the 
median at least once in a total of 6-pair array analyses. For these spots, a statistical 
program called significance analysis of microarrays (SAM) (Tusher et al., 2001) was 
used to identify genes with significant changes in expression levels in the diabetic 
state. Genes for 13 and 57 spots were significantly up-regulated at 1 and 3 months, 
respectively, after STZ injection, with a false discovery rate (FDR) of 23.1 and 9.3%. 
No significantly down-regulated genes were detected at both time points.  
When recurrent genes were integrated, the up-regulated genes were assembled 
into 5 and 15 species at 1 and 3 months, respectively (Tables 1 and 2). Interestingly, 
a number of genes could be classified into a limited number of functional categories: 
mitochondrial DNA-encoded proteins (Table 1, Nos. 1, 4, 5; Table 2, Nos. 2, 5, 6, 8); 
nuclear DNA-encoded mitochondrial proteins (Table 2, Nos. 4, 9, 13); ribosomal 
proteins (Table 2, Nos. 12, 14); and ubiquitin (Table 1, No. 3; Table 2, No. 10). All of 
the mitochondrial DNA- and nuclear DNA-encoded mitochondrial proteins are 
involved in oxidative phosphorylation, i.e., electron transfer and following ATP 
synthesis. Ribosomal proteins and ubiquitin are involved in protein synthesis and 
degradation, respectively. 
To examine the validity of the microarray analysis, we performed Northern 
analysis (Fig. 3) for the mRNA levels of cytochrome c oxidase subunit (COX) 1, 
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COX3, ATPase subunits 6 and 8, ribosomal protein S6 (see Fig. 5A), and ubiquitin, 
using mRNA-derived amplified sense-strand cRNAs (Fig. 1, Steps 10, 11, and E). 
The mRNA levels of these proteins at 3 months after STZ injection were elevated in 
the retina of diabetic mice compared to control mice in all 3 pairs. The increases in 
these mRNA levels were specific, because no apparent change was observed in the 
mRNA levels for rhodopsin. Therefore, the results of microarray analysis were 
validated. We then focused on the regulation of genes for oxidative phosphorylation 
and protein turnover. 
 
3.3. Regulation of genes for oxidative phosphorylation 
 
Because a number of genes involved in mitochondrial oxidative phosphorylation 
was determined to be significantly up-regulated by the SAM method, and because 
recent studies of diabetic muscle (Mootha et al., 2003; Patti et al., 2003) 
demonstrated that modest but coordinated changes in the expression of 
functionally-related genes can be associated with disease phenotypes, we examined 
the changes in the expression levels for all of the mitochondrial DNA-encoded (Fig. 
4A) and nuclear DNA-encoded (Fig. 4B) oxidative phosphorylation-related genes 
contained in our in-house microarray.  
Mitochondrial DNA encodes 13 genes for mitochondrial proteins, all of which 
are components of the oxidative phosphorylation pathway, while more than 60 other 
components of the pathway are encoded by the nuclear DNA, synthesized in the 
cytosol, and post-translationally imported into the mitochondria (Maechler and 
Wollheim, 2001; Wallace, 1999). All of the 13 mitochondrial DNA-encoded genes 
were found in our array (Fig. 4A), and were assembled into 10 mRNA/cDNA species 
because more than one gene shared an identical transcript. The mRNA levels of all 
the 13 genes were elevated, mostly significantly, in the retina of diabetic mice 
13 
compared to control mice at 1 and 3 months after STZ injection, with generally 
higher elevation at 3 months (Fig. 4A). Thus, these genes appeared to be regulated 
in a coordinated manner.  
For nuclear DNA-encoded mitochondrial protein genes, we found 13 spots for 
oxidative phosphorylation genes with adequate fluorescence intensities in our array 
(Fig. 4B). A number of these genes were up-regulated in the diabetic retina at 1 
and/or 3 months after STZ treatment. Therefore, both mitochondrial DNA- and 
nuclear DNA-encoded genes involved in oxidative phosphorylation were 
up-regulated under diabetic conditions, suggesting that this pathway is potentially 
activated in the diabetic retina. Because glycolysis and the citric acid cycle are in 
close relationship with oxidative phosphorylation in the context of glucose 
metabolism, we also examined the expression of genes for these pathways (Fig. 4C). 
The gene for pyruvate kinase M was significantly up-regulated at 3 months, while the 
gene for phosphoglycerate mutase was slightly but significantly down-regulated at 1 
month. 
 
3.4. Regulation of genes for protein turnover 
 
The genes for both ribosomal proteins and ubiquitin were significantly 
up-regulated in the analysis by the SAM method (Tables 1 and 2). This prompted us 
to examine other spots on the array for genes involved in protein synthesis and 
degradation. Figure 5A shows the results for ribosomal proteins and translational 
initiation and elongation factors. A number of genes were up-regulated at 1 and/or 3 
months after STZ injection, suggesting an activation of protein synthesis in the 
diabetic retina. Figure 5B shows the results for the ubiquitin-proteasome system, 
while the number of spots for this system with adequate intensities in our array was 
limited. The gene for ubiquitin specific protease 20, in addition to the ubiquitin gene, 
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was significantly up-regulated in the diabetic retina at 1 month after STZ injection. 
On the other hand, the gene for proteasome subunit β type 6 was significantly 
down-regulated at 3 months.  
Taken together with the up-regulation of genes for protein synthesis, the 
turnover of at least a part of the protein population appears to be activated in the 
retina under the diabetic condition.  
 
 
4. Discussion 
 
We have found that the genes for oxidative phosphorylation are up-regulated in 
the diabetic retina. This was in sharp contrast with the previous reports for a  
down-regulation of these genes in the skeletal muscle of STZ-induced diabetic mice 
(Yechoor et al., 2002; Yechoor et al., 2004) and type 2 diabetic humans (Mootha et 
al., 2003; Patti et al., 2003). It was also reported that mitochondrial proteins for 
electron transfer were decreased in the heart of STZ-treated rats (Turko and Murad, 
2003). Coincidently, insulin treatment of the diabetic mice corrected the repression 
of genes for oxidative phosphorylation in the skeletal muscle (Yechoor et al., 2002; 
Yechoor et al., 2004), and hyperinsulinemic euglycemic clamp of healthy humans 
increased the expression of those genes (Rome et al., 2003). 
What is the cause of these differences between the retina and muscle in the 
regulation of genes for oxidative phosphorylation under diabetic conditions? A highly 
likely explanation for this is the difference of insulin dependency of glucose 
transporters between the retina and muscle. While the glucose transporter GLUT4 of 
the skeletal muscle and myocardium requires insulin for its activity, the retinal 
transporters GLUT1 and GLUT3 are insulin-independent (Kumagai, 1999). GLUT1 
and GLUT3 are major components of the transporters in BRB and the neural retina. 
15 
Insulin independency of these transporters causes hyperglycemia-facilitated influx of 
glucose and a resultant increase in glucose concentration in the neural retina under 
diabetic conditions. In turn, the increase in intracellular glucose concentration 
appears to activate genes for oxidative phosphorylation as an adaptive response to 
consume glucose. On the other hand, glucose import into the muscle under the 
diabetic condition is severely impaired because of the insulin dependency of GLUT4, 
even in the hyperglycemic state. Down-regulation of genes for oxidative 
phosphorylation in the diabetic muscle appears to be an adaptive response in the 
direction opposite to that of the retina, while the down-regulation can also be a 
causative factor of type 2 diabetes (Mootha et al., 2003). Possible differential effects 
of insulin on the retina and muscle in the diabetic state remain to be examined. 
The up-regulation of genes for oxidative phosphorylation in the diabetic retina is 
remarkable from the viewpoint of possible preventive and therapeutic interventions 
of diabetic retinopathy. The critical role of superoxide overproduced by excess 
glucose loading has been remarked in triggering diabetic complications in a number 
of cell types through several mechanisms such as increased polyol pathway flux, 
increased advanced glycation end-product (AGE) formation, activation of protein 
kinase C, and increased hexosamine pathway flux (Brownlee, 2001). The possible 
activation of the pathway for oxidative phosphorylation revealed in the present study 
is a double-edged sword for superoxide production: the first half of the pathway, i.e., 
the electron transfer system generates, while the latter half, i.e., ATP synthase, 
consumes the mitochondrial membrane potential, the elevation of which enforces 
production of superoxide. Despite this ambivalence, the augmented capacity for 
oxidative phosphorylation can be utilized to degrade excess intracellular glucose and 
its metabolites responsible for diabetic complications, by supplying oxygen 
appropriately. Elimination of the excess metabolites might also ameliorate retinal 
edema by reducing the osmotic pressure of intra- and/or intercellular fluid in the 
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retina. 
Our results also suggested that protein turnover rates are increased in the 
diabetic retina. Previously, it was reported that insulin activates genes for protein 
synthesis and the ubiquitin-proteasome system in the human skeletal muscle (Rome 
et al., 2003). Therefore, one can imagine that in the diabetic skeletal muscle these 
genes are down-regulated, although up- or down-regulation of the genes for the 
ubiquitin-proteasome system in the STZ-induced diabetic mice is controversial 
(Yechoor et al., 2002). In general, regulation of genes for protein turnover in the 
retina is different from that in the skeletal muscle under the diabetic condition, 
apparently reflecting again the difference of glucose influx and resultant energy 
availability between the two tissues. 
To date, only a limited number of retinal proteins such as rhodopsin (Illing et al., 
2002; Obin et al., 1996) and the transducin γ-subunit (Obin et al., 2002; Obin et al., 
1996) are known to be ubiquitinated. It was reported (Obin et al., 2002) that 
ubiquitination and subsequent degradation of the transducin γ-subunit were 
prevented by phosducin, suggesting a unique mechanism for the protection of the 
light-dependently dissociated transducin complex. Identification of specific proteins 
under the control of the ubiquitin-proteasome system with altered turnover rates in 
the diabetic retina may provide further insights into the molecular pathophysiology of 
the retinopathy. 
In summary, genes for both energy-producing oxidative phosphorylation and for 
energy-consuming protein turnover are generally up-regulated in the retina under the 
diabetic condition, which is strikingly different from that in the skeletal muscle. 
Augmented capacity for intermediary metabolism can be utilized in preventive and 
therapeutic interventions of diabetic retinopathy. 
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(Figure legends) 
 
Fig. 1.  Schematic representation of the system for construction and analysis of the 
cDNA microarray. See text for detailed explanations. 
 
Fig. 2.  Classification of retinal cDNAs on the microarray. A total of 2,880 cDNA 
clones derived from the mouse retina were classified based on the 5'-terminal 
sequence. The percentages of classified cDNAs are represented as a pie chart. 
Actual cDNA numbers are shown in parentheses. 
 
Fig. 3.  Northern blot analysis with amplified cRNAs for changes in mRNA levels in 
the diabetic retina. (Left column) Northern blot analysis of retinas from three pairs of 
control (C) and diabetic (D) mice. Amplified sense-strand cRNAs (0.25 μg per lane) 
derived from the retinas of three pairs of control and diabetic mice at 3 months after 
STZ injection were subjected to Northern analysis for COX1, COX3, ATPase 
subunits 6 and 8, ribosomal protein S6, and ubiquitin mRNAs. The level of rhodopsin 
mRNA was also determined as a standard showing no significant change. Brackets 
on the left of chemiluminograms indicate ranges subjected to densitometric 
quantification. Background correction was done by subtracting the densitometric 
value of an area with no visible transcripts within the same lane. Below 
chemiluminograms, the quantified results for each pair are presented as values 
relative to the control. Ethidium bromide staining of a representative gel is shown at 
the bottom. Bars represent positions of 28S and 18S rRNAs. (Right column) 
Graphical summary of the densitometric quantification. Results are presented as 
mean + S.E. for the three pairs of retinas. Significant differences were determined by 
the test of population mean: *, P < 0.03; **, P < 0.00005. 
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Fig. 4.  Changes in expression levels of genes for oxidative phosphorylation and 
glucose metabolism. Fold changes in expression levels for mitochondrial 
DNA-encoded (A) and nuclear DNA-encoded genes for oxidative phosphorylation 
(B), and genes for glycolysis and the citric acid cycle (C) in the retina of diabetic 
mice at 1 and 3 months after STZ injection are shown relative to the levels of control 
mice (mean + S.E.). Significant differences were determined by the test of 
population means: *, P < 0.03; **, P < 0.002; ***, P < 0.00005. 
 
Fig. 5.  Changes in expression levels of genes for protein turnover. Fold changes in 
expression levels of genes for protein synthesis (A) and the ubiquitin-proteasome 
system (B) in the retina of diabetic mice at 1 and 3 months after STZ injection are 
shown relative to the levels of control mice (mean + S.E.). Significant differences 
were determined by the test of population means: *, P < 0.03; **, P < 0.002; ***, P < 
0.00005. 
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3. Figure
No. Accession Gene name Fold change
1 J01420 Cytochrome c oxidase subunit I (mitochondrial genome) 1.21
2 X13605 Replacement variant histone H3.3 1.19
3 X51703 Ubiquitin 1.16
4 J01420 Cytochrome c oxidase subunit III (mitochondrial genome) 1.13
5 J01420 ATP synthase subunits 6 and 8 (mitochondrial genome) 1.08
*Delta=1.25, FDR 23.1%.
Table 1
Genes significantly* up-regulated 1 month after STZ injection in the mouse retina
4. Table
No. Accession Gene name Fold change
1 AF032872 Potassium channel regulatory protein KChAP 1.60
2 AB049357 Cytochrome c oxidase subunit I (mitochondrial genome) 1.57
3 L08075 Phosducin 1.53
4 AF315374 ATP synthase lipid-binding protein P3 precursor (Atp5g3) 1.36
5 J01420 ATP synthase subunits 6 and 8 (mitochondrial genome) 1.35
6 U47430 Mitochondrial DNA type 1 control region and flanking tRNA
genes (mitochondrial genome)
1.35
7 AF201948 PIL protein 1.32
8 J01420 Cytochrome c oxidase subunit III (mitochondrial genome) 1.31
9 M20152 Cytochrome c oxidase subunit VIc 1.31
10 X51703 Ubiquitin 1.31
11 Novel EST 1.27
12 BC002044 Ribosomal protein S17 1.27
13 S70447 F1F0-ATP synthase complex Fo membrane domain f subunit 1.26
14 X76772 Ribosomal protein S3 1.23
15 AF073992 Heterogenous nuclear ribonucleoprotein U (hnRNP U) 1.21
*Delta=1.25, FDR 9.3%.
Table 2
Genes significantly* up-regulated 3 months after STZ injection in the mouse retina
4. Table
